Salvatore Piano
@salvatore_piano
Followers
2K
Following
4K
Media
115
Statuses
666
Hepatologist, Internist @UniPadova | interests: cirrhosis, AKI, ACLF, 🦠, 💊 | love traveling, ⚽️, 🏀 and @Inter
Joined June 2015
🚨Don't miss the 4th #LIVERAIM webinar! Early detection of Chronic Liver Disease in primay care: real-world perspectives 🗓️Tomorrow, 16:15-17:CET register here: https://t.co/CBedgBRcnM
@IHIEurope @EASLedu @WoncaWorld
0
2
3
Today’s #readoftheweek📚 explores the accuracy of bedside ultrasound measurement of the rectus femoris cross-sectional area in assessing sarcopenia and its prognostic value in patients with #cirrhosis. Read here this @JHEP_Reports article: https://t.co/1WrnZUd4jX
0
3
7
@BavenoCoop Baveno VIII consensus 27-28 MARCH 2026 secure your spot ⏩ https://t.co/HVWYzPUFRm
@EASLnews @AASLDtweets @APASLnews @INASL_Liver
0
11
25
💥A simple & reliable #POCUS method to assess #sarcopenia in #cirrhosis - now in @JHEP_Reports ✅ Accurate vs CT ⚡️ Fast (1-min test) 💵 Low-cost 🎯 Linked to clinical outcomes 🏥 https://t.co/Q7Tmc77IPu
@hepocus @docMPK @docberza @CirrhosisCareAB @ebtapper @EASLnews
4
23
56
📢Our August issue is out❗️ Featured article: 🟣Risk of portal hypertensive complications preventable by TIPS in patients with ascites: https://t.co/KcUxom8GEV 📖 Dive into the full issue now 👉 https://t.co/6Hyce6IQfP
#LiverTwitter
@EASLedu
@EASLnews
0
14
27
🚨 Don't miss the third webinar of the #LIVERAIM series! 📹 https://t.co/hJwGaYAgge
#livertwitter #SLDthinktank
@IHIEurope @EASLedu
0
6
11
We’ll miss you so much Jaime 🖤 Thank you for being such a true inspiration…
🖤 With deep sorrow, we announce the passing of Prof. Dr. Jaime Bosch, President of the Baveno Cooperation. A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure. Rest in peace, Jaime
0
2
16
Who has lower probability of recompensation? 1️⃣⬆️ MELD 2️⃣🤕further decompensation before etiological cure 🤔 Point of non return? 3️⃣⬆️ BMI 🤔 underlying MASLD? More data are coming @AASLDtweets … @ReibergerThomas @BavenoCoop
0
6
24
📣New data on cirrhosis recompensation in @JHepatology ✅Only 7% meets strict Baveno VII criteria ✅Expanded criteria capture ~38% with similar low mortality risk Recompensation: ⬇️systemic inflammation🔥 👍 improved hemodynamic ⬆️improved survival https://t.co/xPcE25dPcC
3
43
114
Today at the municipality of Riese Pio X, in Italy, we screened over 110 citizens with Fibroscan and identified asymptomatic individuals at high risk of #liver disease. Liver diseases are silent and dangerous: prevention and early diagnosis make all the difference.
0
8
31
🩸 New data add to current evidence on #PlasmaExchange in ACLF: TPE may improve short-term survival in selected patients unresponsive ☞ More work needed to define who benefits & when #LiverTwitter #EASL #INASL #EFCLIF
https://t.co/FcJ6EEDCfy
0
20
42
Now happening at #EASL2025
@schattenbergJ and @PoseElisa highlighting the @LiverAim project at EASL track Hub 8. @EASLnews @IHIEurope
0
1
27
🌎Did you know 1 in 3 adults worldwide has #MASLD? It’s tied to obesity, diabetes & high cholesterol, it can lead to fibrosis and cancer. This @WorldLiverDay remember: 🥦#FoodIsMedicine! 💪Let's make #liverhealth a priority1 @IHIEurope #LIVERAIM
0
9
14
Huge collective effort from International Club of Ascites 🙏🏻 thank you @EASLnews for supporting this project
1
0
3
📣@ICA_Global_AKI published in @LancetGastroHep 🗺️3,821 patients with cirrhosis ✅38% had AKI ⚠️discrepancies in AKI management and outcomes ⚠️ AKI ➡️22.9% 28-day mortality 🎯Need for equitable & standardized care https://t.co/B24femgEfL
thelancet.com
This study found important regional differences in AKI severity, phenotype, management, and outcomes in patients with decompensated cirrhosis. Health-care coverage remains an important driver of...
5
33
84
🚀#LIVERAIM is on the move! Biomarker analysis for early liver fibrosis detection has started at #CORELAB of @hospitalclinic on 22k+ serum samples from general and high-risk populations. 🔎Watch how science is shaping the future! #livertwitter
@IHIEurope @idibaps @EASLnews
2
11
16
⌛️4 day left! 🔗Join 2nd #LIVERAIM webinar and discover what patients really think about #earlydiagnosis: the hopes, the fears, and the reality! 🗓️3 March 17:30-18:10 CET 👉Register now! https://t.co/9Xlsvzb7Ch
#livertwitter #beatingliverdisease #changingtheparadigm
0
7
8
🚨The second #LIVERAIM webinar is on the way! "Early diagnosis of chronic liver disease - What does it mean for patients?" 🗓️ 3 March 17:30-18:10 CET 🔗Register now! https://t.co/x9XPilu80w
#livertwitter #earlydiagnosis #changingtheparadigm
0
10
14
#Chronicliverdisease is a public health thread. #earlydiagnosis can improve patients' outcomes & QoL. ❓What does an early diagnosis mean for patients, families & caregivers? 🗓️3 March 17:30-18:10 CET 👉 Join the second #LIVERAIM webinar! https://t.co/x9XPiluFQ4
1
15
15